AMBAR ALZHEIMER MANAGEMENT BY ALBUMIN REPLACEMENT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AMBAR ALZHEIMER MANAGEMENT BY ALBUMIN REPLACEMENT Trademark

Serial Number: 88385590 • Registration: 6040370

AMBAR ALZHEIMER MANAGEMENT BY ALBUMIN REPLACEMENT is a trademark filed by GRIFOLS WORLDWIDE OPERATIONS LIMITED on April 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GRIFOLS WORLDWIDE OPERATIONS LIMITED (78 trademarks)

GRANGE CASTLE, CLONDALKIN
DUBLIN 22 , IE

Entity Type: 11

Trademark Details

Filing Date

April 15, 2019

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Arranging and conducting educational colloquiums, conferences or congresses; Providing information about education; publication of on-line electronic books and journals; Practical training in the field of Plasma Protein Replacement Therapies; Publication of texts other than publicity texts; Arranging and conducting seminars, symposiums or workshops in the field of Plasma Protein Replacement Therapies; Teaching in the field of Plasma Protein Replacement Therapies; Educational services, namely, conducting classes, courses and workshops in the field Plasma Protein Replacement Therapies; Instruction services, namely, conducting classes, courses and workshops in the field of Plasma Protein Replacement Therapies

Computer programs and software recorded and downloadable for use in database management in the field of Plasma Protein Replacement Therapies; Electronic publications in the nature of journals, reports from scientific congresses and clinical trial studies in the field of Plasma Protein Replacement Therapies

Pharmaceutical preparations for Plasma Protein Replacement Therapies; Diagnostic preparations for medical purposes, namely, plasma-derived protein preparation for medical purposes; Biological preparations for use with Plasma Protein Replacement Therapies for the treatment of Alzheimer's disease and other cognitive disorders

Printed publications in the nature of journals and reports from scientific congresses, and educational and teaching materials in the field of Plasma Protein Replacement Therapies; Printed promotional materials, namely, pamphlets, brochures and reports from clinical trial studies in the field of medical treatments for Alzheimer's disease; Books in the field of Plasma Protein Replacement Therapies; Booklets in the field of Plasma Protein Replacement Therapies; Catalogues in the field of Plasma Protein Replacement Therapies; Diagrams for illustrating plasma protein replacement therapy; Printed flyers in the field of Plasma Protein Replacement Therapies; Printed forms; Graphic prints and graphic art reproductions and representations; Newsletters about Plasma Protein Replacement Therapies; Pictures

Compilation of information into computer databases; Compilation of statistics; Computerized file management; Distribution of samples for publicity purposes; Document reproduction; Organization of exhibitions for commercial and advertising purposes; Organization of trade fairs for commercial and advertising purposes; Outdoor advertising; Radio and television advertising; Wholesale and retail store services in shops and on-line via global computer networks featuring pharmaceutical, biological and diagnostic preparations for medical purposes, computer programs and software recorded or downloadable, electronic publications, medical apparatus and instruments, printed publications, teaching materials, books, booklets, catalogues, diagrams, flyers, printed forms, graphic prints, reproduction and representations, newsletters and pictures

Healthcare; Convalescent home services; Hospital services; Medical clinic services; Medical assistance; Medical equipment rental; Nursing home services; Palliative care; Therapy services, namely, Plasma Protein Replacement; Services of a psychologist

Medical apparatus and instruments, namely, medical apparatus and instruments for the treatment of Alzheimer's disease and other cognitive disorders

Biological research; conducting clinical trials for others; Rental of computer software; Electronic data storage; Installation and maintenance of computer software; Quality control of goods and services; Packaging design; Research and development of new products for others; Scientific laboratory services; Scientific research; Conducting feasibility studies in the field of new technologies for Plasma Protein Replacement Therapies; Technology consultation in the field of Plasma Protein Replacement Therapies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 28, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 6, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2019 CNRT
ASSIGNED TO EXAMINER
May 29, 2019 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 16, 2019 AMPX
ASSIGNED TO LIE
May 7, 2019 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 2, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2019 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 30, 2019 PARI
NEW APPLICATION ENTERED
Apr 18, 2019 NWAP